DNLI – denali therapeutics inc. (US:NASDAQ)
Stock Stats
News
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
Denali Therapeutics (NASDAQ:DNLI) was given a new $37.00 price target on by analysts at Stifel Nicolaus.
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights [Yahoo! Finance]
Denali Therapeutics Announces Board and Executive Leadership Updates [Yahoo! Finance]
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
Form 144 Denali Therapeutics Inc. Filed by: Ho Carole
Form 8-K Denali Therapeutics Inc. For: Dec 04
Form 8-K Denali Therapeutics Inc. For: Dec 04
Form 4 Denali Therapeutics Inc. For: Nov 04 Filed by: Van Hauwermeiren Timothy
Form 3 Denali Therapeutics Inc. For: Nov 04 Filed by: Van Hauwermeiren Timothy
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.